Pharmacology bioRxiv
Not all nitazenes are equal: DFNZ spares brain oxygen where fentanyl and etonitazene do not
- Oxygen sensors in freely moving rats compared three nitazenes with fentanyl, tracking tissue oxygen under the skin and in the nucleus accumbens.
- All compounds lowered subcutaneous oxygen similarly, but the brain picture diverged: most drove hypoxia followed by rebound, and etonitazene caused the deepest, longest dip.
- DFNZ barely affected brain oxygen, and only at far higher doses, suggesting nitazene analgesics need compound-by-compound safety assessment.
DFNZ sparing brain oxygen while fentanyl and etonitazene do not is the interesting split, but without dose-matched analgesia (e.g. ED50-equivalent doses) it could simply mean DFNZ was underdosed centrally. Nucleus accumbens oxygen is also a regional vascular and metabolic readout, not ventilation. Next step: plethysmography or blood gases at matched analgesic exposure, with brain concentrations measured.
Paper: bioRxiv ↗ Distinct changes in brain and peripheral oxygen levels induced by synthetic opioids of the nitazene family